GSK’s bid to dominate longer-life HIV drugs: podcast

By
1 minute read

A participant with a red ribbon pin takes part in an HIV/AIDS awareness campaign ahead of World Aids Day, in Kathmandu, Nepal, November 30, 2016. REUTERS/Navesh Chitrakar

Register now for FREE unlimited access to Reuters.com

LONDON, July 5 (Reuters Breakingviews) - Deborah Waterhouse and Dr Kimberly Smith have spent decades battling the deadly virus. In this edition of The Exchange podcast, the leaders of the British drug giant discuss breakthroughs in the $26 bln market and how Gilead is also making a play for the growing sector.

Listen to the podcast

Follow @aimeedonnellan on Twitter

(The host is a Reuters Breakingviews columnist. The opinions expressed are her own.)

Register now for FREE unlimited access to Reuters.com
Editing by Sharon Lam

Our Standards: The Thomson Reuters Trust Principles.

Opinions expressed are those of the author. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.